CTLA4 and cancer: Intriguingly, a small sample of PLWH who received cICB treatment (targeting PD-1 and CTLA-4) for comorbid cancers saw a marked increase in CD8+ T cell effector function [88] and significant decreases in replication competent HIV-1 [89], respectively.